A patient with a disorder involving endothelial dysfunction associated with deficient nitric oxide bioactivity, e.g., coronary artery disease, atherosclerosis, hypertension, diabetes or neurodegenerative condition stemming from ischemia and/or inflammation, is treated by administering nitric oxide bioactivity...http://www.google.ca/patents/US6784178?utm_source=gb-gplus-sharePatent US6784178 - Pharmacotherapy for vascular dysfunction associated with deficient nitric oxide bioactivity
